Ticker Details
Kezar Life Sciences, Inc.
IPO Date:	June 18, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$53.86M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.23 | 3.11%
Avg Daily Range (30 D):	$0.05 | 0.63%
Avg Daily Range (90 D):	$0.08 | 1.12%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.13M
Avg Daily Volume (90 D):	.07M

Trade Size
Avg Trade Size (Sh.):	134
Avg Trade Size (Sh.) (30 D):	177
Avg Trade Size (Sh.) (90 D):	165

Institutional Trades
Total Institutional Trades:	547
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$1.04M
Avg Institutional Trade (90 D):	$1.04M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.61M
Avg Closing Trade (30 D):	$1.82M
Avg Closing Trade (90 D):	$1.82M
Avg Closing Volume:	23.86K

News

Apr 14, 2026 @ 8:13 PM Are KZR, EQH, ULYX Obtaining Fair Deals for their ... Source: Halper Sadeh Llc

Oct 17, 2025 @ 6:38 PM Kezar Launches Strategic Review As FDA Roadblock D... Source: Vandana Singh

Oct 5, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Oc... Source: Benzinga Insights

Oct 4, 2023 @ 1:32 PM Kezar (KZR) Falls 10% on Strategic Update, Reduces... Source: Zacks Equity Research

Sep 21, 2023 @ 11:51 AM Why Murphy Canyon Acquisition Shares Are Trading H... Source: Lisa Levin

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-6.17	$-.78	$-1.99
Diluted EPS	$-6.17	$-.78	$-1.99
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-45.23M	$-5.76M	$-14.55M
Operating Income / Loss	$-48.84M	$-7.37M	$-15.16M
Cost of Revenue
Net Cash Flow	$29.23M	$-5.65M	$32.94M
PE Ratio